ClearBridge Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.5M | Sell |
352,488
-336,094
| -49% | -$51M | 0.04% | 304 |
|
|
2025
Q1 | $104M | Sell |
688,582
-86,631
| -11% | -$13M | 0.09% | 221 |
|
|
2024
Q4 | $143M | Sell |
775,213
-315,779
| -29% | -$58.3M | 0.12% | 175 |
|
|
2024
Q3 | $215M | Sell |
1,090,992
-277,513
| -20% | -$54.7M | 0.17% | 130 |
|
|
2024
Q2 | $283M | Sell |
1,368,505
-144,633
| -10% | -$29.9M | 0.23% | 106 |
|
|
2024
Q1 | $410M | Buy |
1,513,138
+45,079
| +3% | +$12.2M | 0.33% | 82 |
|
|
2023
Q4 | $347M | Sell |
1,468,059
-277,935
| -16% | -$65.7M | 0.3% | 87 |
|
|
2023
Q3 | $342M | Sell |
1,745,994
-4,116
| -0.2% | -$807K | 0.33% | 84 |
|
|
2023
Q2 | $368M | Buy |
1,750,110
+343,076
| +24% | +$72.1M | 0.33% | 82 |
|
|
2023
Q1 | $284M | Buy |
1,407,034
+36,176
| +3% | +$7.3M | 0.27% | 99 |
|
|
2022
Q4 | $299M | Sell |
1,370,858
-78,671
| -5% | -$17.1M | 0.3% | 93 |
|
|
2022
Q3 | $285M | Sell |
1,449,529
-19,153
| -1% | -$3.77M | 0.29% | 92 |
|
|
2022
Q2 | $314M | Buy |
1,468,682
+99,739
| +7% | +$21.3M | 0.29% | 89 |
|
|
2022
Q1 | $389M | Buy |
1,368,943
+301,159
| +28% | +$85.5M | 0.29% | 90 |
|
|
2021
Q4 | $402M | Buy |
1,067,784
+540,217
| +102% | +$204M | 0.27% | 92 |
|
|
2021
Q3 | $218M | Buy |
527,567
+135,189
| +34% | +$55.8M | 0.16% | 145 |
|
|
2021
Q2 | $145M | Buy |
392,378
+104,250
| +36% | +$38.6M | 0.1% | 184 |
|
|
2021
Q1 | $83.5M | Buy |
288,128
+62,023
| +27% | +$18M | 0.06% | 255 |
|
|
2020
Q4 | $56.5M | Buy |
226,105
+90,937
| +67% | +$22.7M | 0.04% | 314 |
|
|
2020
Q3 | $30.6M | Buy |
+135,168
| New | +$30.6M | 0.03% | 354 |
|